Steve James

Associate Director Biosimilar Sales, Uk @Biogen

GB

Direct line management responsibility for 4 Biosimilar KAM’s and 1 National Market Access Lead across UK/NI with previous experience of managing the Irish Biosimilar portfolio and KAM team.• Successful multi-year revenues of ~£115m per annum across the portfolio Vs AOP targets• The ability to collaborate and engage with strategically important customers, e.g, NHSE tender leads, Regional/National procurement leads & Trust Pharmacists as well as homecare companies.• Key member of the launch Strategy Team for Byooviz resulting in the strongest performance across Europe. • Ireland – Delivered the successful implementation of Flixabi 5-pack improving cost margins and winning new business.• Supply chain lead for UK across the portfolio to ensure un-broken supply chain. • Lead & drive implementation of Strategic Account Management strategy to support life cycle management.• Development & roll out of a new multi-channel sales model in UK, Europe, and the US• Supported the team to drive implementation of the updated NICE TA715, focusing on moderate RA patients & pathway inclusion strategy.• Experienced in developing pricing council proposals to secure required price to effectively tender brands in both pre and post launch phases.• Collaborated to deliver the “Commercial Excellence project” which supports the continued development of a high-performance sales organisation.